0000899243-17-002273.txt : 20170131
0000899243-17-002273.hdr.sgml : 20170131
20170131160535
ACCESSION NUMBER: 0000899243-17-002273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170130
FILED AS OF DATE: 20170131
DATE AS OF CHANGE: 20170131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Madison Greg
CENTRAL INDEX KEY: 0001564955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 17561171
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DRIVE
CITY: LEXINGTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-30
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001564955
Madison Greg
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
1
1
0
0
President and CEO
Common Stock
2017-01-30
4
S
0
18248
4.65
D
235322
D
Sale of a total of 18,248 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 51,251 shares of restricted stock on January 27, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 118,790 shares of restricted stock.
/s/ Brian Adams, Attorney-in-Fact
2017-01-31